The Physical Therapy Residency Program offers licensed physical therapist an opportunity to advance their knowledge and skills in orthopaedic specialty practice
COVID In Colorado: First Lung Transplant, Calls To The Unvaccinated, Reaching BIPOC People, Cases And More cpr.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cpr.org Daily Mail and Mail on Sunday newspapers.
E-Mail
Dr. Jaime Butler-Dawson, from the Center for Health, Work, & Environment (CHWE) within the Colorado School of Public Health (ColoradoSPH), has received a Career Development Award from the National Institutes of Health. The three-year K01 grant from the National Institute of Environmental Health Sciences will provides support to examine the environmental determinants of kidney injury in female sugarcane workers and female community members in Guatemala.
Dr. Butler-Dawson is a research instructor in the Department of Environmental and Occupational Health (EOH) at the ColoradoSPH and is a founding member of the Climate, Work and Health Initiative. Her new study is part of CHWE s efforts to identify and prevent exposures that may contribute to the epidemic of chronic kidney disease of unknown origin (CKDu) in Central America.
Image courtesy of Accuray
April 23, 2021 A phase 1 clinical trial led by investigators at the University of Chicago Medicine testing the effects of stereotactic body radiotherapy for treating multiple metastases has determined that treatments used for single tumors can also be safely used for treating patients with multiple metastases. The study was run through NRG Oncology and sponsored by the National Cancer Institute. The results were published on April 22 in JAMA Oncology.
Cancer is traditionally treated with a combined approach, with clinicians using surgery, chemotherapy and radiation therapy to kill and remove cancerous tumors. Systemic treatments such as chemotherapy often are not enough to stop the cancer’s growth.
E-Mail
A phase 1 clinical trial led by investigators at the University of Chicago Medicine testing the effects of stereotactic body radiotherapy for treating multiple metastases has determined that treatments used for single tumors can also be safely used for treating patients with multiple metastases. The study was run through NRG Oncology and sponsored by the National Cancer Institute. The results were published on April 22 in
Cancer is traditionally treated with a combined approach, with clinicians using surgery, chemotherapy and radiation therapy to kill and remove cancerous tumors. Systemic treatments such as chemotherapy often are not enough to stop the cancer s growth.